QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,923 signal articles · 510 in last 24h · 106,112 total before filter · latest 48m ago
510last 24h
2485last 7d
486● bullish (7d)
255● bearish (7d)
200publishers
AllMacro168Earnings1551M&A138Regulatory15Product8Analyst21
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Microsoft is Soaring After Earnings While Meta Platforms Drops. Is The Market Giving Zuckerberg Too Little Credit?
24/7 Wall St.2d agobearishVIDEO
Microsoft is Soaring After Earnings While Meta Platforms Drops. Is The Market Giving Zuckerberg Too Little Credit?

On the latest episode of the AI Investor Podcast, 24/7 Wall St. Analyst Austin Smith opens with a puzzle: two companies are being treated in opposite ways for the same underlying behavior. Microsoft is up roughly 16% after Azure growth accelerated from 38% to 43%, with guidance pointing to 45–46%, vindicating a capex program the market had criticized. Meta, meanwhile, is down about 10% at roughly 20x earnings despite 28% top-line growth — and is being punished for the same infrastructure spending, even after Zuckerberg argued that Meta rents out compute at a markup over its cost. Co-host Eric Bleeker's answer is that both moves are likely overreactions, and that the real variable is what each company said versus what Wall Street wanted to hear. Microsoft delivered on message: Azure at a $124 billion run rate, 90% of cloud demand coming from outside the frontier labs, and no capex increase. He frames Microsoft's position as a prisoner's dilemma, since compute routed to Azure is compute unavailable for its own AI products, and argues Microsoft CEO Satya Nadella relented under pressure from prior quarters. He compares the market's discomfort with capex growth to Apple's mid-decade smartphone choppiness versus Google's steadier trajectory. Meta hit every wrong note: an EPS miss on one-time costs, decelerating guidance, Zuckerberg walking back the cloud-capacity revenue opportunity, and incremental compute directed toward Meta Superintelligence rather than the core ad business. Eric estimates the justified moves were only a few percent in either direction, with the rest attributable to PR and positioning. He credits Microsoft's software exposure as valuable diversification, but concludes the share-price gap doesn't reflect any real difference in business trajectory.

Is Intel (INTC) Fairly Valued Following Q2 Guidance And AI Partnership Updates?
Simply Wall St.2d agobullish
Is Intel (INTC) Fairly Valued Following Q2 Guidance And AI Partnership Updates?

Intel (INTC) heads into the Future of Memory and Storage 2026 conference in Santa Clara with investors weighing fresh Q2 results, updated revenue guidance, and new AI focused partnerships across PCs, packaging, and foundry services. See our latest analysis for Intel. Intel’s recent conference buzz, new AI PC and packaging collaborations, and stronger Q2 guidance sit against a mixed price pattern. The share price is up 10.92% over one day and 16.96% over seven days, yet down 16.13% over 30...

Charles Schwab (SCHW) Stock Still Looks Cheap On Fair Value Yet Fair On Earnings
Simply Wall St.2d agoneutral
Charles Schwab (SCHW) Stock Still Looks Cheap On Fair Value Yet Fair On Earnings

Charles Schwab stock has delivered a 69.3% return over the past three years, yet its current checks still suggest the shares may be trading below an intrinsic value estimate based on the Excess Returns model. After that kind of run, the key issue for investors is whether the current price already reflects the recent strength in the business or whether there is still a margin between market price and intrinsic value. A 69.3% return over three years indicates Charles Schwab has already...

Amgen Q2 Earnings Call Highlights
MarketBeat2d agoneutral
Amgen Q2 Earnings Call Highlights

Amgen (NASDAQ:AMGN) reported second-quarter revenue above $10 billion, up 10% from a year earlier, as growth across several key medicines offset competitive pressure on its bone-health franchise. The company raised its full-year revenue and adjusted earnings outlook while continuing to increase spen

Astera Labs Q2 Earnings Call Highlights
MarketBeat2d agoneutral
Astera Labs Q2 Earnings Call Highlights

Astera Labs (NASDAQ:ALAB) reported record second-quarter revenue and projected a sharp sequential increase for the third quarter, citing accelerating demand for its AI infrastructure connectivity products and the volume-production ramp of its Scorpio X-Series fabric switches. Revenue for the second

How Compass Earnings Blew Past Estimates in a Lousy Housing Market
Barrons.com2d agobullish
How Compass Earnings Blew Past Estimates in a Lousy Housing Market

Compass stock was rising in after-hours trading after the company reported earnings and issued guidance that exceeded consensus estimates. Compass’s ongoing integration of the Anywhere brokerage business and partnership with Redfin helped. Compass reported basic earnings of twelve cents a share, or eleven cents a share diluted, on $4.3 billion in revenue in its second quarter, the real estate brokerage said in a Tuesday announcement.

TransMedics (TMDX) Q2 Earnings Lag Estimates
Zacks2d agoneutral
TransMedics (TMDX) Q2 Earnings Lag Estimates

TransMedics (TMDX) delivered earnings and revenue surprises of -12.00% and +3.14%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?